76 Engineering-"https:" "https:" "https:" "UCL" positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
to help maintain and support employees’ well-being and work-life balance, please see our working with us webpages Where to apply Website https://www.timeshighereducation.com/unijobs/listing/406574/clinical
-
of intergenerational relations and population change. The Centre is led by Professor Jane Falkingham. For further details, see https://www.cpc.ac.uk/research_programme/connecting_generations/ This project will examine
-
engineered cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of paediatric cancer neoantigens. Building on strong preliminary data, it combines mechanistic and translational immunology
-
a Horizon Europe Pathfinder science-to-technology breakthrough, targeting a paradigm shift in fabricating a novel optically active crystal – rare-earth (RE) doped sapphire (REDS). The EIC-funded
-
for the digital services that underpin the work of NIHRCC and also offer support to the School. Further information can be found at: https://www.nihr.ac.uk . You are encouraged to review our operational priorities
-
-of-the-art structural modelling and computational protein design approaches to understand and engineer enzymes that modify IgG Fc N-linked glycans. The successful candidate will use tools such as AlphaFold
-
The University of Southampton is a world-leading institution for aircraft noise research, home to the Rolls-Royce University Technology Centre in Gas Turbine Noise at the Institute of Sound and
-
Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC). EXPRESS is a large (£10M
-
, and this role offers the unique chance to realise significant opportunities at a major inflection point for this emerging technology. You will join a collaborative, supportive group and have opportunity
-
engineered cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of paediatric cancer neoantigens. Building on strong preliminary data, it combines mechanistic and translational immunology